Medicine
Fotivda 0.89 mg capsule
Fotivda 0.89 mg capsule is a prescription medicine containing Tivozanib for oral use, marketed by AVEO Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 ° C to 25 ° C (68 ° F to 77 ° F), excursions permitted between…
Key facts
- Active ingredient (INN)
- Tivozanib
- Brand
- Fotivda
- Strength
- 0.89 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 1 bottle
- Marketing authorisation holder
- AVEO Pharmaceuticals
- Manufacturer
- AVEO Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20 ° C to 25 ° C (68 ° F to 77 ° F), excursions permitted between 15°C to 30 ° C (59°F to 86 ° F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01EK03 Tivozanib
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 March 2021
- Identifiers
- RxCUI 2534238, 2534244, 2534247 +1DailyMed set ID de77155c-ecf2-4f15-9758-21d271449d83NDC 45629-089Application NDA212904
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, plastic in 1 carton / 21 capsule in 1 bottle, plastic | 45629-089-02 | AVEO Pharmaceuticals | 30 January 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Tivozanib
Clinical summary
Tivozanib is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies. It is available as capsules for oral use. MedsAcross supplies Tivozanib for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TivozanibFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- FOTIVDA prescribing information (AVEO Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Fotivda: European public assessment report (EPAR) · European Medicines Agency
Need Fotivda 0.89 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.